Author

F. Valafar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. D. Baughn· 1 shared A. Elghraoui· 1 shared B. M. Gorman· 1 shared D. Conkle-Gutierrez· 1 shared J. M. Thiede· 1 shared M. D. Howe· 1 shared N. Dillon· 1 shared R. Aflakpui· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. D. Baughn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Novel and Reported Compensatory Mutations in rpoABC Associate Specifically with Predominant Mycobacterium tuberculosis Rifampicin Resistance Marker rpoB:S450L

D. Conkle-Gutierrez, S. M. Ramirez-Busby, B. M. Gorman, A. Elghraoui, S. E. Hoffner, W. Elmaraachli, F. Valafar

bioRxiv · Feb 22, 2022 · PreprintMicrobiology

Pyrazinamide action is driven by the cell envelope stress response in Mycobacterium tuberculosis

J. M. Thiede, N. Dillon, M. D. Howe, S. J. Modlin, R. Aflakpui, S. Hoffner, F. Valafar, Y. Minato, A. D. Baughn

This study identifies that the cell envelope stress response drives pyrazinamide susceptibility in Mycobacterium tuberculosis, independent of pH, and shows that peptidoglycan synthesis inhibitors enhance its action.

bioRxiv · Feb 17, 2021 · PreprintMicrobiology